Showing results (1601-1610 of 1,942) with videos related to

Sort By:
Pageof 195
Antimicrobial Agents and Chemotherapy|May 11, 2016
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human EnzymeAndrew G S Warrilow, Josie E Parker, Claire L Price, et al.
Molecular Medicine (Cambridge, Mass.)|June 6, 2022
Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridineJames B Machamer, Edwin J Vazquez-Cintron, Sean W O'Brien, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|November 25, 2018
Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1-/- mouse brain and plasmaWilliam J Griffiths, Peter J Crick, Anna Meljon, et al.
Physiology & Behavior|March 12, 2022
Something new and something blue: Responses to novelty in a rodent model of depression and epilepsy comorbidityStellan K Ryan-Coats, Sara D Hughes, Faith M Holz, et al.
Connective Tissue Research|April 12, 2012
Decorin expression, straw-like structure, and differentiation of human costal cartilageM W Stacey, J Grubbs, A Asmar, et al.
British Journal of Pharmacology|January 1, 1991
Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptorJ E Merritt, T J Hallam, A M Brown, et al.
Journal of Wildlife Diseases|November 14, 1998
Acute effects of lead, steel, tungsten-iron, and tungsten-polymer shot administered to game-farm mallardsM E Kelly, S D Fitzgerald, R J Aulerich, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 29, 2021
Optimizing cluster survey designs for estimating trachomatous inflammation-follicular within trachoma control programsJulia W Gallini, Eshetu Sata, Mulat Zerihun, et al.
Pageof 195